echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > External media: rose fruit extract can slow down the growth of cancer cells and prevent breast cancer

    External media: rose fruit extract can slow down the growth of cancer cells and prevent breast cancer

    • Last Update: 2015-04-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In a new study, rose fruit extract significantly reduced cell growth and metastasis of triple negative breast cancer, foreign media said This aggressive cancer does not respond to most of the existing therapies and tends to attack young women, African Americans, and Hispanics "Doctors, patients and researchers are all looking for alternative treatments for triple negative breast cancer," said Patrick Martin, research director and associate professor at North Carolina State University of agriculture and technology Taking one vitamin tablet a day from rose fruit may help prevent or treat cancer It's a natural product and we found it to be effective with no side effects " Triple negative breast cancer gets its name because the cancer cells in those tumors lack three growth factor receptors Most of the existing treatments are ineffective for this cancer In the study, scientists used several rose fruit extracts to treat three negative breast cancer cells At the highest concentration, the proliferation of triple negative breast cancer cells decreased by 50% With the decrease of the concentration, the effect also weakened The highest concentration of rose fruit extract reduced the metastasis of three negative breast cancer cells by 25% to 45% Extracts appear to work by reducing mitogen activated protein kinase (MAPK) and protein kinase B (Akt), two enzymes that promote the growth of triple negative breast cancer cells The extract also enhanced the efficacy of adriamycin, a commonly used chemotherapy drug for breast cancer, and reduced the receptors in cultured tissues Most of the existing treatments have no effect on this cancer In the study, scientists used several rose fruit extracts to treat three negative breast cancer cells At the highest concentration, the proliferation of triple negative breast cancer cells decreased by 50% With the decrease of the concentration, the effect also weakened The highest concentration of rose fruit extract reduced the metastasis of three negative breast cancer cells by 25% to 45% Extracts appear to work by reducing mitogen activated protein kinase (MAPK) and protein kinase B (Akt), two enzymes that promote the growth of triple negative breast cancer cells The extract also enhanced the efficacy of adriamycin, a commonly used chemotherapy drug for breast cancer, and reduced cell proliferation and metastasis in cultured tissues The incidence rate of cancer in Macao is the highest The number of cancer is increasing year by year Chen Naizhi, Liang Yiluan, Xiong Weijia and Lv Zhenying, President of the Macao hematology and cancer association, have been interviewed Beijing, March, 30, according to the Macao daily, breast cancer is the highest incidence rate of cancer among women in Macao in recent 10 years The number of cases is increasing and younger Doctors in Macao and Hong Kong say that early detection and early treatment of breast cancer will greatly improve the cure rate and reduce mental and breast trauma They call on women over 40 years old to have regular mammography Women with family history suggest that they should have mammography every year from 30 to 35 years old Young women can also have self-examination after menstruation The "2015 International Forum on Chinese and Western medicine tumor treatment" hosted by the Macao society of Hematology and oncology medicine was held at the Macau Huangdu hotel from 28 to 29 this month Cancer specialists from Macao medical organizations and experts and scholars from both sides of the Taiwan Strait were invited to participate in the conference, focusing on the research of Chinese and Western medicine in breast cancer, breast screening and blood tumor treatment and development The incidence rate of Macao is catching up with the clinical instructor Liang Yiluan, who is a teacher of the European and American Health Sciences College of Macao University of science and technology Breast cancer is one of the most common malignant tumors in women According to the global statistics, the incidence rate is 7% to 10% of all kinds of malignant tumors in the body The annual increase rate of death is about 2%, and the number of new cases of breast cancer worldwide is over 1 million The incidence rate of incidence of breast cancer in Macao is catching up with the proportion of the European and American countries The incidence rate of breast cancer in Macao has increased by 26% from 2003 to 2012 In the past 10 years, breast cancer is the highest incidence rate of cancer in women, and the number of people with breast cancer has been increasing and younger The mortality rate of breast cancer in Macao is not the highest In 2012, breast cancer accounted for 45% and the mortality rate was 8.5% At the age of 40, breast cancer should be examined every year, which is a serious threat to women's health At present, the world is not clear about the factors that cause breast cancer It is suggested that people should start from daily life, have good diet and living habits, reduce pressure, regulate their own endocrine, and prevent the occurrence of cancer Liang Yiluan called on women over 40 to go to the hospital for breast examination every year Even young women have the chance to have breast cancer They can check their breasts for lumps and discomfort after menstruation At present, the treatment direction of breast cancer is comprehensive, and the cure rate is higher than that of other cancers Doctors usually choose radiotherapy and chemotherapy after surgery in combination with various factors of patients At present, the examination and treatment technology in Macao is in line with the international standards The earlier the treatment, the higher the survival rate Xiong Weijia, an honorary clinical assistant professor of surgery from the University of Hong Kong and clinical tutor of HKUST hospital, said that the international treatment of breast cancer is a comprehensive plan, with surgery as the first step The purpose is to remove the tumor, provide pathological reports and follow-up work The treatment methods also include electrotherapy, chemotherapy, targeted drugs and hormonal treatment Targeted treatment and hormonal treatment are relatively new Methods of treatment In the first stage of breast cancer treatment, the 5-year survival rate is as high as 90%, in the second stage, the 5-year survival rate is reduced to 70%, in the third stage, 50%, and in the fourth stage, only 20% He called on women to have regular medical examination and self-examination If they have any discomfort, they should go to the hospital for consultation and confirmation They should find the initial tumor through mammography, and find the cure rate and effect as soon as possible Lu Zhenying, a radiology specialist at the Hong Kong Women's imaging diagnostic center, said that early cancer can be found in mammography surveys If you are over 40 years old, you should have an annual check-up and early detection, so you can have more treatment options The age of breast cancer in Hong Kong is between 40 and 65, with an average age of more than 50 years, which is lower than the average age of more than 60 years in Europe and America If the direct family member has breast cancer and has a family genetic history, it is recommended that the woman aged 30-35 years old or above should have an annual contrast examination The World Health Organization recommends that women over the age of 40 should have regular breast examinations and annual medical examinations Women can have their own examinations after menstruation (2015-03-30 16:10:11) extended reading Egypt found the earliest evidence of breast cancer from the bones of female aristocrats 4000 years ago Reference information network reported on March 25 that the research team of the University of Haan in Spain found the bones of an adult female with a history of 4200 years, which is the oldest evidence of breast cancer in the world in the mouth of Egyptian authorities According to Taiwan's "Central News Agency" which assisted Lutou news agency on the 24th, Mamdouh El damaty, the Ministry of antiquities, said that the skeleton of the woman who lived in the end of the sixth dynasty "deteriorated seriously" "The study of her remains shows the typical destructive damage caused by metastasis and spread of breast cancer," he said in a statement on the 24th Cancer is one of the top causes of death in the world today, but compared with other diseases, cancer is almost absent from archaeological records, so that some people think that cancer is mainly due to the modern lifestyle and the extension of human life But the discovery, combined with the 3000 year old metastatic cancer skeleton found in a grave in modern Sudan last year by British scholars, shows that cancer existed in ancient times in the Nile Valley According to the archaeology team of the University of Jaen, the Egyptian woman is an aristocrat from Elephant Island Egypt's antiquities ministry said the team excavated her remains from a prehistoric cemetery in qubbet El Hawa, west of the southern city of Aswan (2015-03-25 09:23:48) extended reading of the gospel of breast cancer patients after surgery Xiangnan Kamakura general hospital, located in Kamakura, Kanagawa County, announced Monday that it will carry out self stem cell breast reconstruction treatment in the near future to help those patients who lose or deform their breasts due to breast cancer surgery The safety and effectiveness of this treatment has been confirmed by clinical trials According to the Tokyo news on January 22, it is expected that the treatment implementation plan will be approved by the relevant departments in February, and once approved, the patients' application will be accepted quickly According to the hospital, this breast reconstruction through "fat stem cell transplantation" is the first time in Japan The head of plastic and cosmetic surgery of the hospital, Rihua Yamashita and others attended the press conference In the process of fat stem cell transplantation, the subcutaneous fat of the abdomen or thigh of the patient should be extracted first Half of the fat cells are used to make new blood vessels, and the stem cells with the ability to regenerate fat are separated The remaining half of the fat cells are washed and mixed with the stem cells and injected into the focus Fat transplantation has been widely used before, but the survival rate is only 10% - 40% The survival rate of adipose stem cell transplantation can reach 70% - 80%, and it is not easy to cause complications and side effects Mr Yamashita and his team carried out clinical trials on 5 patients aged 40-60 years after breast cancer surgery from October to December 2013, all of which achieved good results "There was no serious problem, the treated part looked more beautiful, and all five patients were satisfied," Yamashita said It is said that the breast will continue to grow if treated many times (2015-01-23 10:03:00) extended reading Japan's promotion of blood collection and screening for cancer risk can screen for breast cancer and lung cancer Beijing, Jan 19 - according to Japanese media reports on Jan 19, more and more medical institutions in Japan are introducing a screening method to detect the possibility of cancer by measuring and analyzing the concentration variation of 20 amino acids in the blood According to the report, it has the advantage that only about 5ml of blood can be collected each time, and several cancers can be detected at the same time, which is very convenient People who were tested were given a high-risk screening test for the cancer The test is known as the amino acid indicator cancer risk screening (AICS) This is the clinical application of the technology developed by weizhisu Now it is possible to screen for gastric, lung, colorectal and prostate cancer in men and gastric, lung, colorectal and breast cancer in women In addition, although the possibility of cervical cancer, uterine body cancer and ovarian cancer cannot be individually screened, the possibility of some of them can be judged The ratio of amino acid concentration in the blood of normal people almost keeps a certain value If the organ changes, the concentration will change subtly Because the change mode shows different characteristics due to different organs and etiology, it can be used to judge the possibility of cancer Based on 0-10, AICS can be divided into class A (0.0-4.9), class B (5.0-7.9), and class C (8.0-10.0) Although the AICS values vary according to the type of cancer, the risk of type C cancer is 4.0 to 11.6 times higher than that of ordinary people According to weizhisu, about 900 medical facilities in Japan are now implementing the screening method, and the number is increasing year by year The total number of personnel inspected is about 9
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.